PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Current SP appreciation, page-187

  1. 300 Posts.
    lightbulb Created with Sketch. 38
    Furthermore to support this, go to Twitter Dr. John Michels M.D. Not one single tweet since the company Announcement, surely if he was the lead Physician for the Phase III trial in the USA he would be the 1st to tweet it and promote it as it would be within his and Paradigm's best interests? Feel free to call me a idiot but you cannot dispute what I have just stated. Check his Twitter account. Something is wrong IMO
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.